Cargando…
Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective
A large proportion of medicines used in children are prescribed off-label, and children have often been denied access to new or innovative medications. Because such situation is unethical, the need to obtain paediatric information for medicines used in children seems nowadays a matter of consensus o...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629463/ https://www.ncbi.nlm.nih.gov/pubmed/19063723 http://dx.doi.org/10.1186/1753-2000-2-38 |